Acad Emerg Med

1. MCLEAN K, Johnson TJ
   Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report.
   Acad Emerg Med. 2021;28:918-921.
   

   >> Share

   
   
2. JORGE GARCIA-LAMBERECHTS E, Miro O, Fragiel M, Llorens P, et al
   A case-control analysis of stroke in Covid-19 patients: Results of Unusual Manifestations of Covid-19-Study 11.
   Acad Emerg Med. 2021 Sep 7. doi: 10.1111/acem.14389.
   

   >> Share

   
   

   
   AJR Am J Roentgenol

3. CANON C, Chick JFB, Dequesada I, Gunderman RB, et al
   Physician Burnout in Radiology: Perspectives From the Field.
   AJR Am J Roentgenol. 2021 Sep 8. doi: 10.2214/AJR.21.26756.
   

   >> Share

   
   
4. DONTCHOS BN, Achibiri J, Mercaldo SF, Wang GX, et al
   Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic.
   AJR Am J Roentgenol. 2021 Sep 8. doi: 10.2214/AJR.21.26597.
   

   >> Share

   
   

   
   Am J Obstet Gynecol

5. PAPAGEORGHIOU AT, Gunier RB, Villar J
   The link between COVID-19 and Preeclampsia.
   Am J Obstet Gynecol. 2021 Sep 6. pii: S0002-9378(21)00984.
   

   >> Share

   
   
6. MOHINI, Ahmed S, Kasarla V, Rath SK, et al
   Worse Outcomes of Pregnancy in COVID-19 Infection during Parturition may be due to Referral Bias: Analysis in a Prospective Cohort of 963 pregnancies.
   Am J Obstet Gynecol. 2021 Sep 4. pii: S0002-9378(21)00995.
   

   >> Share

   
   
7. BOELIG RC, Aagaard KM, Debbink MLP, Shamshirsaz AA, et al
   SMFM Special Statement: COVID-19 Research in Pregnancy: Progress and Potential.
   Am J Obstet Gynecol. 2021 Sep 2. pii: S0002-9378(21)00976.
   

   >> Share

   
   
8. DESSEAUVE D, Pomar L, Baud D
   INTERCOVID prospective longitudinal study: preeclampsia and COVID-19.
   Am J Obstet Gynecol. 2021 Sep 2. pii: S0002-9378(21)00980.
   

   >> Share

   
   

   
   Am J Respir Crit Care Med

9. BHAVANI SV, Luo Y, Miller WD, Sanchez-Pinto LN, et al
   Simulation of Ventilator Allocation in Critically Ill Patients with COVID-19.
   Am J Respir Crit Care Med. 2021 Sep 9. doi: 10.1164/rccm.202106-1453.
   

   >> Share

   
   
10. JAIN A
    Olfactory-nasal Nitric-oxide Link in COVID-19: A Marker of Neurogenesis or Risk Factor for Chronic Rhinosinusitis?
    Am J Respir Crit Care Med. 2021 Sep 7. doi: 10.1164/rccm.202107-1697.
    

    >> Share

    
    
11. DINH-XUAN AT, Hua-Huy T
    Reply to: Olfactory-nasal Nitric-oxide Link in COVID-19: A Marker of Neurogenesis or Risk Factor for Chronic Rhinosinusitis?
    Am J Respir Crit Care Med. 2021 Sep 7. doi: 10.1164/rccm.202108-1827.
    

    >> Share

    
    

    
    Ann Intern Med

12. MAKI DG
    In suspected COVID-19, RT-PCR with nasal plus throat swabs has 97% sensitivity vs. nasopharyngeal swabs.
    Ann Intern Med. 2021 Sep 7. doi: 10.7326/ACPJ202109210.
    

    >> Share

    
    

    
    BMJ

13. 
    Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.
    BMJ. 2021;374:n2091.
    

    >> Share

    
    
14. LUM R
    Covid-19: Malaysia hit by record cases despite prolonged lockdown.
    BMJ. 2021;374:n2155.
    

    >> Share

    
    
15. DYER C
    Covid-19: "Most complex patient in the world" should have ventilation withdrawn.
    BMJ. 2021;374:n2193.
    

    >> Share

    
    
16. TANCREDI S, Anker D, Rosella L, Chiolero A, et al
    Elimination of covid-19: beware of surveillance bias.
    BMJ. 2021;374:n2126.
    

    >> Share

    
    
17. IACOBUCCI G
    Covid-19: JCVI opts not to recommend universal vaccination of 12-15 year olds.
    BMJ. 2021;374:n2180.
    

    >> Share

    
    
18. SRIVASTAVA K
    Covid-19: Why has India had a spike in stillbirths?
    BMJ. 2021;374:n2133.
    

    >> Share

    
    
19. TORJESEN I
    Covid-19: Infection increases the risk of kidney disease even in mild cases, finds study.
    BMJ. 2021;374:n2189.
    

    >> Share

    
    

    
    Clin Infect Dis

20. GRINT DJ, Wing K, Houlihan C, Gibbs HP, et al
    Severity of SARS-CoV-2 alpha variant (B.1.1.7) in England.
    Clin Infect Dis. 2021 Sep 6. pii: 6365124. doi: 10.1093.
    

    >> Share

    
    
21. GUARALDI G, Milic J, Martinez E, Kamarulzaman A, et al
    Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era.
    Clin Infect Dis. 2021;73:e1222-e1227.
    

    >> Share

    
    
22. KULKARNI O, Narreddy S, Zaveri L, Kalal IG, et al
    Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection Without Mutations in the Spike Protein.
    Clin Infect Dis. 2021;73:e1239-e1241.
    

    >> Share

    
    
23. LEE M
    Lack of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Antibodies to Seasonal Coronaviruses: Making Sense of the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2021;73:e1212-e1213.
    

    >> Share

    
    
24. BAROCAS JA, Savinkina A, Lodi S, Epstein RL, et al
    Projected long-term impact of the COVID-19 pandemic on hepatitis C outcomes in the United States: a modelling study.
    Clin Infect Dis. 2021 Sep 9. pii: 6367757. doi: 10.1093.
    

    >> Share

    
    
25. TO KK, Li X, Lung DC, Ip JD, et al
    False COVID-19 cases due to contamination by inactivated virus vaccine.
    Clin Infect Dis. 2021 Sep 9. pii: 6367446. doi: 10.1093.
    

    >> Share

    
    

    
    Emerg Infect Dis

26. BAJ A, Novazzi F, Pasciuta R, Genoni A, et al
    Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy.
    Emerg Infect Dis. 2021;27.
    

    >> Share

    
    

    
    Infect Control Hosp Epidemiol

27. MYHRMAN S, Olausson J, Ringlander J, Gustavsson L, et al
    Unexpected details regarding nosocomial transmission revealed by whole-genome sequencing of severe acute respiratory coronavirus virus 2 (SARS-CoV-2).
    Infect Control Hosp Epidemiol. 2021 Aug 20:1-5. doi: 10.1017/ice.2021.
    

    >> Share

    
    
28. JUDSON SD, Munster VJ
    A framework for nosocomial transmission of emerging coronaviruses.
    Infect Control Hosp Epidemiol. 2021;42:639-641.
    

    >> Share

    
    
29. FRAM DS, Escudero DVDS, Matias LO, Coelho WEGS, et al
    Personal protective equipment: Shortage or waste?
    Infect Control Hosp Epidemiol. 2021;42:786-787.
    

    >> Share

    
    
30. DEVOE C, Segal MR, Wang L, Stanley K, et al
    Increased Rates of Secondary Bacterial Infections, Including Enterococcus Bacteremia, in Patients Hospitalized with COVID-19.
    Infect Control Hosp Epidemiol. 2021 Sep 6:1-33. doi: 10.1017/ice.2021.
    

    >> Share

    
    
31. REDMOND SN, Li DF, Haq MF, Jones LD, et al
    Frequent detection of severe acute respiratory syndrome coronavirus 2 RNA on hands and skin of patients with coronavirus disease 2019.
    Infect Control Hosp Epidemiol. 2021 Sep 6:1-7. doi: 10.1017/ice.2021.
    

    >> Share

    
    
32. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    COVID-19 infection of health care personnel after complete COVID-19 vaccination.
    Infect Control Hosp Epidemiol. 2021 Sep 6:1-3. doi: 10.1017/ice.2021.
    

    >> Share

    
    
33. PANAGET B, Velay A, Gontard L, Severac F, et al
    High SARS-CoV-2 seroconversion rate among geriatric staff from Strasbourg University Hospitals.
    Infect Control Hosp Epidemiol. 2021 Sep 6:1-12. doi: 10.1017/ice.2021.
    

    >> Share

    
    
34. CINTRA NMF, Felisberto TCB, Limeira IC, de Carli MLD, et al
    The quiet before the storm: negligence and inappropriateness in face mask use in the community preceded devastating second wave of COVID-19 in Brazil.
    Infect Control Hosp Epidemiol. 2021 Sep 6:1-6. doi: 10.1017/ice.2021.
    

    >> Share

    
    
35. SANTANA LADM, Lima Dos Santos MA, de Albuquerque HIM, de Oliveira EM, et al
    Post-acute COVID-19 syndrome in maxillofacial surgeons after initial infection: a Brazilian experience.
    Infect Control Hosp Epidemiol. 2021 Sep 6:1-7. doi: 10.1017/ice.2021.
    

    >> Share

    
    
36. TANDE AJ, Pollock BD, Shah ND, Binnicker M, et al
    mRNA Vaccine Effectiveness Against Asymptomatic SARS-CoV-2 Infection Over a Seven-Month Period.
    Infect Control Hosp Epidemiol. 2021 Sep 6:1-7. doi: 10.1017/ice.2021.
    

    >> Share

    
    

    
    Int J Infect Dis

37. LOUCA S
    SARS-CoV-2 infections in 165 countries over time.
    Int J Infect Dis. 2021 Sep 3. pii: S1201-9712(21)00701.
    

    >> Share

    
    
38. THANGARAJU P, B AK, Venkatesan S
    Vigilance in selection of low-dose versus high-dose steroids in COVID-19.
    Int J Infect Dis. 2021;109:54-55.
    

    >> Share

    
    
39. NGERE I, Dawa J, Hunsperger E, Otieno N, et al
    sssHigh seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya.
    Int J Infect Dis. 2021 Sep 2. pii: S1201-9712(21)00696.
    

    >> Share

    
    
40. VICENTI I, Basso M, Gatti F, Scaggiante R, et al
    Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose.
    Int J Infect Dis. 2021 Sep 2. pii: S1201-9712(21)00683.
    

    >> Share

    
    
41. SATO K, Mano T, Niimi Y, Toda T, et al
    Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of self-reporting database.
    Int J Infect Dis. 2021 Sep 4. pii: S1201-9712(21)00704.
    

    >> Share

    
    

    
    Intensive Care Med

42. RIERA J, Roncon-Albuquerque R Jr, Fuset MP, Alcantara S, et al
    Increased mortality in patients with COVID-19 receiving extracorporeal respiratory support during the second wave of the pandemic.
    Intensive Care Med. 2021 Sep 9. pii: 10.1007/s00134-021-06517.
    

    >> Share

    
    
43. BARRAL M, Arrive L, El Mouhadi-Barnier S, Cornelis FH, et al
    Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration.
    Intensive Care Med. 2021;47:1034-1036.
    

    >> Share

    
    

    
    J Infect

44. OLEARO F, Norz D, Hoffman A, Grunwald M, et al
    Clinical performance and accuracy of a qPCR-based SARS-CoV-2 mass-screening workflow for healthcare-worker surveillance using pooled self-sampled gargling solutions: a cross-sectional study.
    J Infect. 2021 Sep 6. pii: S0163-4453(21)00451.
    

    >> Share

    
    
45. QIU S, Zhang Y, Wang D, Hu Y, et al
    The high expression of SARS-CoV-2 cell receptors might lead to higher COVID-19 infection rates in cancer patients.
    J Infect. 2021 Sep 2. pii: S0163-4453(21)00449.
    

    >> Share

    
    
46. ALKALAMOUNI H, Hitti E, Zaraket H
    Adopting fresh air ventilation may reduce the risk of airborne transmission of SARS-CoV-2 in COVID-19 unit.
    J Infect. 2021 Sep 1. pii: S0163-4453(21)00450.
    

    >> Share

    
    

    
    J Med Virol

47. YIGIT M, Ozkaya-Parlakay A, Cosgun Y, Ince YE, et al
    SHOULD A THIRD BOOSTER DOSE BE SCHEDULED AFTER TWO DOSES OF CORONAVAC? A SINGLE CENTER EXPERIENCE.
    J Med Virol. 2021 Sep 6. doi: 10.1002/jmv.27318.
    

    >> Share

    
    
48. KAUR U, Bala S, Mbbs BO, Mbbs SJ, et al
    Occurrence of COVID-19 in priority groups receiving ChAdOx1 nCoV-19 coronavirus vaccine (recombinant): a preliminary analysis from north India.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27320.
    

    >> Share

    
    
49. SARGIN ALTUNOK E, Satici C, Dinc V, Kamat S, et al
    Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave vs the second wave.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27319.
    

    >> Share

    
    
50. TANISLAV C, Kostev K
    Fewer non-Covid-19 respiratory tract infections and gastro-intestinal infections during the Covid-19 pandemic.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27321.
    

    >> Share

    
    
51. UMAIR M, Ikram A, Badar N, Haider SA, et al
    Tracking down B.1.351 SARS-CoV-2 variant in Pakistan through genomic surveillance.
    J Med Virol. 2021 Sep 9. doi: 10.1002/jmv.27328.
    

    >> Share

    
    
52. TSANG AKL, Mak GCK, Leung PKL, Cheng PKC, et al
    Emergence of SARS-CoV-2 lineage B.1.617.2 in the local community of Hong Kong.
    J Med Virol. 2021 Sep 9. doi: 10.1002/jmv.27326.
    

    >> Share

    
    
53. PANDOLFI S, Chirumbolo S
    On reaching herd immunity during COVID-19 pandemic and further issues.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27322.
    

    >> Share

    
    
54. DIVINO F, Ciccozzi M, Farcomeni A, Lasinio GJ, et al
    Unreliable predictions about COVID-19 infections and hospitalizations make people worry: the case of Italy.
    J Med Virol. 2021 Sep 8. doi: 10.1002/jmv.27325.
    

    >> Share

    
    
55. CHAUDHRY R, Sreenath K, Batra P, Vinayaraj EV, et al
    Atypical bacterial co-infections among patients with COVID-19: a study from India.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27324.
    

    >> Share

    
    

    
    J Travel Med

56. TAMANG ST, Lhendup K, Dorji T
    Control of travel-related COVID-19 in Bhutan.
    J Travel Med. 2021 Sep 3. pii: 6363816. doi: 10.1093.
    

    >> Share

    
    
57. KOLLEPARA PK, Siegenfeld AF, Taleb NN, Bar-Yam Y, et al
    Unmasking the mask studies: Why the effectiveness of surgical masks in preventing respiratory infections has been underestimated.
    J Travel Med. 2021 Sep 6. pii: 6365138. doi: 10.1093.
    

    >> Share

    
    
58. TORRES JR
    Are rapid antigen SARS-Cov-2 tests effective for mass screening of travelers at airports? The Olympic experience.
    J Travel Med. 2021 Sep 3. pii: 6363815. doi: 10.1093.
    

    >> Share

    
    
59. ROSCA EC, Heneghan C, Spencer EA, Brassey J, et al
    Transmission of SARS-CoV-2 associated with aircraft travel: A systematic review.
    J Travel Med. 2021 Sep 3. pii: 6363811. doi: 10.1093.
    

    >> Share

    
    

    
    J Virol

60. ANDRADE ACDSP, Gabriel Campolina-Silva H, Queiroz-Junior CM, de Oliveira LC, et al
    A biosafety level-2 mouse model for studying betacoronavirus-induced acute lung damage and systemic manifestations.
    J Virol. 2021 Sep 8:JVI0127621. doi: 10.1128/JVI.01276.
    

    >> Share

    
    
61. CHIEM K, Morales Vasquez D, Silvas JA, Park JG, et al
    A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo.
    J Virol. 2021 Sep 8:JVI0112621. doi: 10.1128/JVI.01126.
    

    >> Share

    
    
62. CHEN HY, Huang C, Tian L, Huang X, et al
    Cytoplasmic tail truncation of SARS-CoV-2 Spike protein enhances titer of pseudotyped vectors but masks the effect of the D614G mutation.
    J Virol. 2021 Sep 8:JVI0096621. doi: 10.1128/JVI.00966.
    

    >> Share

    
    

    
    JAMA

63. KHARBANDA EO, Haapala J, DeSilva M, Vazquez-Benitez G, et al
    Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy.
    JAMA. 2021 Sep 8. pii: 2784193. doi: 10.1001/jama.2021.15494.
    

    >> Share

    
    

    
    Lancet

64. BOSELEY S
    The race to make a COVID-19 vaccine.
    Lancet. 2021;398:832-833.
    

    >> Share

    
    
65. HARVEY SB, Epstein RM, Glozier N, Petrie K, et al
    Mental illness and suicide among physicians.
    Lancet. 2021;398:920-930.
    

    >> Share

    
    
66. ROGAWSKI MCQUADE ET, Breskin A
    Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine.
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01817.
    

    >> Share

    
    
67. KASEJE N, Walcott D
    Global youth advocating for COVID-19 vaccines for all.
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01994.
    

    >> Share

    
    
68. FLAXMAN A, Marchevsky NG, Jenkin D, Aboagye J, et al
    Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01699.
    

    >> Share

    
    
69. JERVING S
    The long road ahead for COVID-19 vaccination in Africa.
    Lancet. 2021;398:827-828.
    

    >> Share

    
    

    
    Lancet Infect Dis

70. ANTONELLI M, Penfold RS, Merino J, Sudre CH, et al
    Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Lancet Infect Dis. 2021 Sep 1. pii: S1473-3099(21)00460.
    

    >> Share

    
    
71. BAGER P, Wohlfahrt J, Rasmussen M, Albertsen M, et al
    Hospitalisation associated with SARS-CoV-2 delta variant in Denmark.
    Lancet Infect Dis. 2021 Sep 3. pii: S1473-3099(21)00580.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

72. SIEGEL DA, Reses HE, Cool AJ, Shapiro CN, et al
    Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0-17 Years - United States, August 2020-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1249-1254.
    

    >> Share

    
    
73. DELAHOY MJ, Ujamaa D, Whitaker M, O'Halloran A, et al
    Hospitalizations Associated with COVID-19 Among Children and Adolescents - COVID-NET, 14 States, March 1, 2020-August 14, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1255-1260.
    

    >> Share

    
    
74. WANGA V, Chevinsky JR, Dimitrov LV, Gerdes ME, et al
    Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1235-1241.
    

    >> Share

    
    
75. REBMANN T, Loux TM, Arnold LD, Charney R, et al
    SARS-CoV-2 Transmission to Masked and Unmasked Close Contacts of University Students with COVID-19 - St. Louis, Missouri, January-May 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1245-1248.
    

    >> Share

    
    
76. KIRBY AE, Walters MS, Jennings WC, Fugitt R, et al
    Using Wastewater Surveillance Data to Support the COVID-19 Response - United States, 2020-2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1242-1244.
    

    >> Share

    
    

    
    N Engl J Med

77. SHAH ASV, Gribben C, Bishop J, Hanlon P, et al
    Effect of Vaccination on Transmission of SARS-CoV-2.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMc2106757.
    

    >> Share

    
    
78. MEANEY-DELMAN DM, Ellington SR, Shimabukuro TT
    On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. Reply.
    N Engl J Med. 2021 Sep 8. pii: 10.1056/NEJMc2113516.
    

    >> Share

    
    
79. SUN H
    On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
    N Engl J Med. 2021 Sep 8. pii: 10.1056/NEJMc2113516.
    

    >> Share

    
    
80. ZAUCHE LH, Wallace B, Smoots AN, Olson CK, et al
    Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMc2113891.
    

    >> Share

    
    
81. DEAN NE, Hogan JW, Schnitzer ME
    Covid-19 Vaccine Effectiveness and the Test-Negative Design.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMe2113151.
    

    >> Share

    
    
82. THOMPSON MG, Stenehjem E, Grannis S, Ball SW, et al
    Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMoa2110362.
    

    >> Share

    
    
83. 
    mRNA Covid-19 Vaccines in Pregnant Women.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMx210017.
    

    >> Share

    
    
84. 
    Surviving Covid-19 with Heparin?
    N Engl J Med. 2021;385:1056.
    

    >> Share

    
    
85. PATRIQUIN CJ, Laroche V, Selby R, Pendergrast J, et al
    Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2109465.
    

    >> Share

    
    
86. 
    Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMx210016.
    

    >> Share

    
    
87. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Assessing Vaccine Safety.
    N Engl J Med. 2021;385:e37.
    

    >> Share

    
    
88. LEVY JH, Connors JM
    Heparin Resistance - Clinical Perspectives and Management Strategies.
    N Engl J Med. 2021;385:826-832.
    

    >> Share

    
    
89. PAPINENI P
    A Pink Salwar.
    N Engl J Med. 2021;385:774-775.
    

    >> Share

    
    

    
    Nature

90. MLCOCHOVA P, Kemp S, Dhar MS, Papa G, et al
    SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
    Nature. 2021 Sep 6. pii: 10.1038/s41586-021-03944.
    

    >> Share

    
    
91. MALLAPATY S
    Kids and COVID: why young immune systems are still on top.
    Nature. 2021;597:166-168.
    

    >> Share

    
    
92. GRAHAM F
    Daily briefing: First ever DNA vaccine authorized for COVID-19 in India.
    Nature. 2021 Sep 3. pii: 10.1038/d41586-021-02417.
    

    >> Share

    
    
93. SAVILLE M
    COVID-19: release approved vaccines for trials of new ones.
    Nature. 2021;597:178.
    

    >> Share

    
    

    
    Radiology

94. GULSIN GS, McVeigh N, Leipsic JA, Dodd JD, et al
    Cardiovascular CT and MRI in 2020: Review of Key Articles.
    Radiology. 2021 Sep 7:211002. doi: 10.1148/radiol.2021211002.
    

    >> Share

    
    

    
    Zhonghua Jie He He Hu Xi Za Zhi

95. LONG QY, Zheng YL, Gao ZC
    [Analysis of the clinical characteristics of COVID-19 reinfection cases].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:793-799.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share